Pharming Group N.V.

€1.10As of Sun 8 Nov 2026, 12:00 UTC
AMS:PHARMHealthcare
Country Netherlands
PE (Fwd) •••
TSR 10Y CAGR 17.37%
Div yield —
ROE 8.70%
Biotechnology
Beta (5Y) 0.05
PE TTM 43.64
TSR TTM (2.95%)
Mkt cap €780.0M
ROIC 15.76%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€1.31
19.07%
98.41%
Hold 9|5|5|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
9.32%
25.99%
35.76%
47.04%
Revenue$M
100.6
102.8
100.5
101.9
6.45%
2.94%
(4.53%)
(1.21%)
Peers (US$875.4M)
Cap (US$)
PE
1.522B
—
Capital
TTM
5Y
10Y
Leveragex
2.920
0.469
0.367
EBIT/Intx
1.529
0.457
0.366
Own earn%
(99.87)
30.01
22.96
Sh yield%
33.40
30.49
29.91
Owners
Insiders/Inst%
14.19
28.73
Short interest%
5.32
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
5–9
$1 testx
—
Incr. ROIC%
6